Regeneron Pharmaceuticals | REGN - تكلفة المبيعات





تكلفة المبيعات تغيير تاريخ
AbbVie USD 4.29B 73M 2026-06
Agenus USD 642K 399K 2025-09
Agios Pharmaceuticals USD 1.32M 560K 2026-03
Alnylam Pharmaceuticals USD 298.45M 87.33M 2026-06
Amgen USD 1.87B 271M 2026-06
Astellas Pharma JPY 158.38B 28.94B 2026-06
AstraZeneca USD 2.52B 2.73B 2026-06
Biogen USD 945.1M 147.6M 2026-06
BioMarin Pharmaceutical USD 276.29M 76.8M 2026-06
Bristol-Myers Squibb USD 7.89B 4.03B 2026-06
Eli Lilly USD 3.27B 309M 2026-06
Gilead Sciences USD 1000M 445M 2026-06
GlaxoSmithKline GBP 2.07B 192M 2026-06
Incyte USD 104.96M 457K 2026-06
Ionis Pharmaceuticals USD 2.74M 261K 2026-06
J&J USD 8B 67M 2026-06
Kyowa Hakko Kirin JPY 39.13B 6.13B 2026-06
Merck USD 3.14B 200M 2026-06
Moderna USD 93M 862M 2026-06
Neurocrine Biosciences USD 39.4M 25.6M 2026-06
Novartis USD 3.71B 251M 2026-06
Novartis USD 3.46B 83M 2026-03
Pfizer USD 4.09B 498M 2026-06
Puma Biotechnology USD 29.1M 18.44M 2024-09
Regeneron Pharmaceuticals USD 576.5M 92.9M 2026-06
Roche Holding CHF 7.85B 630M 2026-06
Sanofi EUR 3.14B 618M 2026-03
Sarepta Therapeutics USD 150.1M 40.64M 2026-06
Teva Pharmaceutical Industries USD 1.98B 30M 2026-06
Ultragenyx Pharmaceutical USD 30M 1000K 2026-03
United Therapeutics USD 99.5M 33.9M 2026-06
Vertex Pharmaceuticals USD 489.2M 96.4M 2026-06